Publication

452P Temozolomide-capecitabine (TemCap) chemotherapy for neuroendocrine neoplasms (NENs): time to maximum response and optimal treatment duration.

Lamarca, Angela
; 
Barriuso, Jorge
; 
McCallum, Lynne
; 
Papaxoinis, Georgios
; 
Nasralla, Magdy
; 
Nuttall, Christina
; 
Frizziero, Melissa
; 
Kordatou, Zoe
; ; ... show 3 more
Citations
Altmetric:
Abstract
Authors
Lamarca, Angela
Barriuso, Jorge
McCallum, Lynne
Papaxoinis, Georgios
Nasralla, Magdy
Nuttall, Christina
Frizziero, Melissa
Kordatou, Zoe
McNamara, Mairéad G
Hubner, Richard A
Manoharan, Prakash
Mansoor, Was
Valle, Juan W
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, Manchester
Description
Date
2017-09
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
452P Temozolomide-capecitabine (TemCap) chemotherapy for neuroendocrine neoplasms (NENs): time to maximum response and optimal treatment duration. 2017, 28(suppl_5): Ann Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620644
Embedded videos